BMG Pharma, a biopharmaceutical and B2B company headquartered in Milan with its chemical plant in Torviscosa (Italy), conducted a clinical study with encouraging results to assess the efficacy of BMG0705 Nasal Spray and BMG0703A Mouth Rinse in the treatment of asymptomatic COVID-19 patients. These positive results could represent the starting point for the use of … Continue reading BMG Pharma: BMG0705 Nasal Spray and BMG0703A Mouth Rinse achieve statistically significant clinical results in preventing COVID-19 and other nasal infections •